NM_013275.6:c.*8G>A
Variant names:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_013275.6(ANKRD11):c.*8G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,205,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.000081 ( 0 hom., cov: 24)
Exomes 𝑓: 0.000032 ( 0 hom. )
Consequence
ANKRD11
NM_013275.6 3_prime_UTR
NM_013275.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.211
Genes affected
ANKRD11 (HGNC:21316): (ankyrin repeat domain containing 11) This locus encodes an ankryin repeat domain-containing protein. The encoded protein inhibits ligand-dependent activation of transcription. Mutations in this gene have been associated with KBG syndrome, which is characterized by macrodontia, distinctive craniofacial features, short stature, skeletal anomalies, global developmental delay, seizures and intellectual disability. Alternatively spliced transcript variants have been described. Related pseudogenes exist on chromosomes 2 and X. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 16-89268470-C-T is Benign according to our data. Variant chr16-89268470-C-T is described in ClinVar as [Benign]. Clinvar id is 2647056.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000809 (11/135960) while in subpopulation EAS AF= 0.00219 (10/4566). AF 95% confidence interval is 0.00119. There are 0 homozygotes in gnomad4. There are 5 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High AC in GnomAd4 at 11 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD11 | NM_013275.6 | c.*8G>A | 3_prime_UTR_variant | Exon 13 of 13 | ENST00000301030.10 | NP_037407.4 | ||
ANKRD11 | NM_001256182.2 | c.*8G>A | 3_prime_UTR_variant | Exon 14 of 14 | NP_001243111.1 | |||
ANKRD11 | NM_001256183.2 | c.*8G>A | 3_prime_UTR_variant | Exon 13 of 13 | NP_001243112.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000810 AC: 11AN: 135858Hom.: 0 Cov.: 24
GnomAD3 genomes
AF:
AC:
11
AN:
135858
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000979 AC: 13AN: 132792Hom.: 0 AF XY: 0.0000975 AC XY: 7AN XY: 71786
GnomAD3 exomes
AF:
AC:
13
AN:
132792
Hom.:
AF XY:
AC XY:
7
AN XY:
71786
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000318 AC: 34AN: 1069314Hom.: 0 Cov.: 15 AF XY: 0.0000335 AC XY: 18AN XY: 537146
GnomAD4 exome
AF:
AC:
34
AN:
1069314
Hom.:
Cov.:
15
AF XY:
AC XY:
18
AN XY:
537146
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000809 AC: 11AN: 135960Hom.: 0 Cov.: 24 AF XY: 0.0000767 AC XY: 5AN XY: 65210
GnomAD4 genome
AF:
AC:
11
AN:
135960
Hom.:
Cov.:
24
AF XY:
AC XY:
5
AN XY:
65210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Mar 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
ANKRD11: BS1, BS2 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at